|
Dr. Martin Abeloff is the Director of the Johns Hopkins Oncology Center. He has been deeply committed to translational research, the transfer of research findings from the laboratory to the clinic, specifically in treatments for breast and lung cancer. He was responsible for the development of the solid tumor clinical research programs in the Oncology Center in the early 1970s and has played a leadership role in the development of broad-based research programs in solid tumors, hematologic malignancies and in cancer prevention and control. At the national level, he served as President of the American Society of Clinical Oncology in 1991-92 and as Chairman of the Oncology Drug Advisory Committee of the FDA. He currently is the Chairman of the Board of Scientific Counselors to the NCI’s Intramural Division of Clinical Sciences at the National Cancer Institute, and is a member of its executive committee. Dr. Abeloff received his medical degree from the Johns Hopkins University School of Medicine. | 